MyChesCo on MSN8h
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational IncomeYARDLEY, PA — Optinose (NASDAQ: OPTN) has announced its financial results for the year and quarter ending December 31, 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback